TABLE 3

Pharmacokinetic parameters of MGS0028 in Sprague-Dawley rats, rhesus monkeys, and beagle dogs

Results are presented as mean (±S.D.), n = 3, except for dog at 0.1 mg/kg p.o., where n = 2.


Parameter

Sprague-Dawley Rat

Rhesus Monkey

Beagle Dog
3 mg/kg i.v.
1 mg/kg p.o.
3 mg/kg p.o.
10 mg/kg p.o.
1 mg/kg i.v.
5 mg/kg p.o.
0.3 mg/kg i.v.
0.1 mg/kg p.o.
0.3 mg/kg p.o.
Cmax (μM) - 1.0 ± 0.2 2.7 ± 0.3 6.0 ± 1.9 - 1.0 ± 0.5 - 1.5 ± 0.8 4.0 ± 1.0
tmax (h) - 0.8 ± 0.2 2.0 ± 0.0 3.0 ± 1.4 - 2.3 ± 1.5 - 0.4 ± 0.1 0.5 ± 0.0
AUC0-24 h (μM · h) 14.3 ± 0.8 3.4 ± 0.5 9.7 ± 1.2 35.8 ± 3.8 10.2 + 2.6 10.4 ± 5.0 8.2 + 1.1 1.7 ± 0.9 5.7 ± 0.3
Effective t1/2 (h) 1.1 - - - 1.1 - 0.9 - -
CLp (ml/min/kg) 16.2 ± 0.9 - - - 8.0 ± 1.8 - 2.8 ± 0.4 - -
Vd (l/kg) 0.5 ± 0.2 - - - 0.6 ± 0.1 - 0.1 ± 0.01 - -
F (%) - 70.7 67.7 75.3 - 20.3* - 63.4 69
AUCMetabolite/AUCParent
0.8
0.4
0.6
0.3
0.3
0.9
0.0
0.0
0.0
  • -, not applicable.

  • * Some monkeys experienced emesis, and this may be partially responsible for low bioavailability.